Log In
Sunday 18th March 2018

MS drug hope

5th June 2008

Makers of a new drug that allows multiple sclerosis patients to walk more quickly has passed the next step in its testing.

Acorda has tested the drug on 240 patients and found that two-fifths showed signs of improvement and now plans to seek a US safety licence next year. The MS Society in the UK said that the drug frampridine – which is aimed at those who are still capable of walking but find it a difficult process - could have a real impact on the quality of life of some patients.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Mayden - Innovative cloud-based applications for healthcare
© Mayden Foundation 2018